Transition of tumor-associated macrophages from MHC class IIhi to MHC class IIlow mediates tumor progression in mice
2011

How Tumor-Associated Macrophages Affect Tumor Growth in Mice

Sample size: 20 publication 10 minutes Evidence: high

Author Information

Author(s): Wang Benfan, Li Qinyan, Qin Li, Zhao Siting, Wang Jinyan, Chen Xiaoping

Primary Institution: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences

Hypothesis

The study investigates the role of tumor-associated macrophages (TAMs) in tumor progression and their MHC class II expression levels.

Conclusion

The study concludes that tumor progression is positively correlated with the infiltration of MHC class IIlow TAMs, suggesting that targeting this transition may be a novel strategy for cancer treatment.

Supporting Evidence

  • Partial depletion of macrophages significantly inhibited tumor growth in mice.
  • MHC class IIhi TAMs were associated with tumor suppression during early tumor development.
  • MHC class IIlow TAMs became predominant as tumors progressed, promoting tumor growth.
  • Clodronate-liposome treatment effectively reduced the number of TAMs in tumor-bearing mice.
  • Increased infiltration of MHC class IIlow TAMs correlated with a suppressive tumor microenvironment.

Takeaway

The study found that certain immune cells called macrophages can help tumors grow, and changing these cells might help fight cancer.

Methodology

The study used Clodronate-encapsulated liposomes to partially deplete TAMs in a murine hepatoma model and analyzed tumor growth and macrophage populations.

Participant Demographics

Female C57BL/6 and BALB/c mice, aged 6-8 weeks.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1471-2172-12-43

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication